前收市價 | 0.3000 |
開市 | 0.4000 |
買盤 | 0.3500 |
賣出價 | 0.7000 |
拍板 | 68.00 |
到期日 | 2024-06-28 |
今日波幅 | 0.4000 - 0.5200 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 10 |
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. Let’s get some of the bad stuff out of the way first. Biotech stocks – even the established players – can be volatile. A miss in the clinical process to commercialize a therapeutic could lead to significant losses. And there’s really no way of reliably forecasting such outcomes. Plus, the sector isn’t always known for delivering predictable financi
There are a handful of different factors that could buoy its stock.